Novelmed patent anti-Properdin (anti-Properdin)
|
Ab209759-1mg
|
ExactAb™, 无载体, 重组, 低内毒素, 无叠氮钠, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
Novelmed patent anti-Properdin (anti-Properdin)
|
Ab209759-10mg
|
ExactAb™, 无载体, 重组, 低内毒素, 无叠氮钠, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Novelmed patent anti-Properdin (anti-Properdin)
|
Ab209759-100μg
|
ExactAb™, 无载体, 重组, 低内毒素, 无叠氮钠, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
ABT-325 (anti-IL18)
|
Ab209750-5mg
|
无载体, ExactAb™, 重组, 低内毒素, 已验证, Azide Free, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
ABT-325 (anti-IL18)
|
Ab209750-1mg
|
无载体, ExactAb™, 重组, 低内毒素, 已验证, Azide Free, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
ABT-325 (anti-IL18)
|
Ab209750-10mg
|
无载体, ExactAb™, 重组, 低内毒素, 已验证, Azide Free, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
ABT-325 (anti-IL18)
|
Ab209750-100μg
|
无载体, ExactAb™, 重组, 低内毒素, 已验证, Azide Free, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
M1295 (anti-IL13)
|
Ab209746-5mg
|
ExactAb™, 已验证, 无载体, 低内毒素, Azide Free, 重组, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
M1295 (anti-IL13)
|
Ab209746-1mg
|
ExactAb™, 已验证, 无载体, 低内毒素, Azide Free, 重组, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
M1295 (anti-IL13)
|
Ab209746-10mg
|
ExactAb™, 已验证, 无载体, 低内毒素, Azide Free, 重组, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
M1295 (anti-IL13)
|
Ab209746-100μg
|
ExactAb™, 已验证, 无载体, 低内毒素, Azide Free, 重组, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Tilogotamab (anti-TNFRSF10B)
|
Ab209738-5mg
|
ExactAb™, Azide Free, 无载体, 重组, 低内毒素, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2109731-10-2 |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
Tilogotamab (anti-TNFRSF10B)
|
Ab209738-1mg
|
ExactAb™, Azide Free, 无载体, 重组, 低内毒素, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2109731-10-2 |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
Tilogotamab (anti-TNFRSF10B)
|
Ab209738-10mg
|
ExactAb™, Azide Free, 无载体, 重组, 低内毒素, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2109731-10-2 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Tilogotamab (anti-TNFRSF10B)
|
Ab209738-100μg
|
ExactAb™, Azide Free, 无载体, 重组, 低内毒素, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2109731-10-2 |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
TRX1 (anti-CD4)
|
Ab209737-5mg
|
ExactAb™, 已验证, 无载体, 重组, Azide Free, 低内毒素, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
TRX1 (anti-CD4)
|
Ab209737-1mg
|
ExactAb™, 已验证, 无载体, 重组, Azide Free, 低内毒素, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
TRX1 (anti-CD4)
|
Ab209737-10mg
|
ExactAb™, 已验证, 无载体, 重组, Azide Free, 低内毒素, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
TRX1 (anti-CD4)
|
Ab209737-100μg
|
ExactAb™, 已验证, 无载体, 重组, Azide Free, 低内毒素, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Brolucizumab (anti-VEGFA)
|
Ab191965-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
1531589-13-5 |
5mg
|
¥ 4199.9
|
期货,请咨询 |
阿拉丁 |
Brolucizumab (anti-VEGFA)
|
Ab191965-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
1531589-13-5 |
1mg
|
¥ 1639.9
|
期货,请咨询 |
阿拉丁 |
Brolucizumab (anti-VEGFA)
|
Ab191965-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
1531589-13-5 |
10mg
|
¥ 6899.9
|
期货,请咨询 |
阿拉丁 |
Brolucizumab (anti-VEGFA)
|
Ab191965-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
1531589-13-5 |
100μg
|
¥ 329.9
|
期货,请咨询 |
阿拉丁 |
Keliximab (anti-CD4)
|
Ab191955-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
174722-30-6 |
5mg
|
¥ 7129.9
|
期货,请咨询 |
阿拉丁 |